WEE1 and cancer: The drugs included in the screening library are low molecular weight protein kinase inhibitors (KI) targeting receptor tyrosine kinases (RTK), e.g. EGFR, and intracellular kinase pathways, e.g. PKC, considered important in cancer cell proliferation and/or survival.